Targeted cancer immunotherapy is a research paper published in Current Opinion in Pharmacology (2013). On theSindex it has a DataRank of 1.4. It has been cited 38 times, with 37 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.550
From this paper's citation signal
Citation Network Contribution
0.824
From 28 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 37 citers.
European Research Council
Grant: 600950
European Commission
Grant: 249898
Eradication of tumors by targeting dsRNA selectively to cancer cells and recruitment of the innate immune system
FWCI
2.97
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals